BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24935874)

  • 1. Antibodies to Delta/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma.
    Greene M; Lai Y; Baella N; Dalmau J; Lancaster E
    JAMA Neurol; 2014 Aug; 71(8):1003-8. PubMed ID: 24935874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration.
    de Graaff E; Maat P; Hulsenboom E; van den Berg R; van den Bent M; Demmers J; Lugtenburg PJ; Hoogenraad CC; Sillevis Smitt P
    Ann Neurol; 2012 Jun; 71(6):815-24. PubMed ID: 22447725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Tr/DNER Antibody-Associated Cerebellar Ataxia: a Systematic Review.
    Campana IG; Silva GD
    Cerebellum; 2022 Dec; 21(6):1085-1091. PubMed ID: 34817790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Ma-associated paraneoplastic cerebellar degeneration in a patient with nodular lymphocyte-predominant Hodgkin lymphoma: a case report.
    Inui R; Saito K; Shimomura Y; Yamashita D; Kawamoto M; Ishikawa T
    BMC Neurol; 2020 Sep; 20(1):355. PubMed ID: 32967629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease.
    Bernal F; Shams'ili S; Rojas I; Sanchez-Valle R; Saiz A; Dalmau J; Honnorat J; Sillevis Smitt P; Graus F
    Neurology; 2003 Jan; 60(2):230-4. PubMed ID: 12552036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin Lymphoma With Diplopia and Nystagmus: A Paraneoplastic Cerebellar Degeneration With Ectopic Expression of DNER Antigen on Reed-Sternberg Cells.
    Fiorelli N; Fraticelli S; Bonometti A; Diamanti L; Paoletti M; Franciotta D; Gotti M; Lucioni M; Paulli M; Arcaini L
    Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):e124-e127. PubMed ID: 34782261
    [No Abstract]   [Full Text] [Related]  

  • 7. Standardized test for anti-Tr/DNER in patients with paraneoplastic cerebellar degeneration.
    Probst C; Komorowski L; de Graaff E; van Coevorden-Hameete M; Rogemond V; Honnorat J; Sabeter L; Graus F; Jarius S; Voltz R; Wildemann B; Franciotta D; Blöcker IM; Schlumberger W; Stöcker W; Sillevis Smitt PA
    Neurol Neuroimmunol Neuroinflamm; 2015 Apr; 2(2):e68. PubMed ID: 25745634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
    Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
    Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Tr/DNER antibody paraneoplastic cerebellar degeneration preceding a very late relapse of Hodgkin Lymphoma after 12 years.
    Christensen PB; Gregersen H; Almasi C
    Cerebellum Ataxias; 2021 Jun; 8(1):14. PubMed ID: 34090521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmapheresis and IVIG for Treatment of Non-Tumor Anti-Tr/DNER Antibody-Associated Ataxia: A Case Report.
    Adibi A; Rastegar-Kashkouli A; Yousefi P; Adibi I; Ahmadi E; Naghavi S
    Cerebellum; 2024 Jun; ():. PubMed ID: 38874737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Tr/DNER antibody-associated cerebellar ataxia: three rare cases report and literature review.
    Cai Y; Liu J; Ren H; Shi F; Che J; Geng Q; Tan Y; Guan H; Di W
    Neurol Sci; 2023 Jan; 44(1):397-403. PubMed ID: 36094774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
    Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
    Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
    Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
    Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.
    Jarius S; Wildemann B
    J Neuroinflammation; 2015 Sep; 12():168. PubMed ID: 26377319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MAZ protein is an autoantigen of Hodgkin's disease and paraneoplastic cerebellar dysfunction.
    Bataller L; Wade DF; Graus F; Rosenfeld MR; Dalmau J
    Ann Neurol; 2003 Jan; 53(1):123-7. PubMed ID: 12509857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic cerebellar degeneration preceding the diagnosis of Hodgkin's lymphoma.
    Ypma PF; Wijermans PW; Koppen H; Sillevis Smitt PA
    Neth J Med; 2006; 64(7):243-7. PubMed ID: 16929086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated ZIC4 antibodies in paraneoplastic cerebellar syndrome with an underlying ovarian tumor.
    Kerasnoudis A; Rockhoff M; Federlein J; Gold R; Krogias C
    Arch Neurol; 2011 Aug; 68(8):1073. PubMed ID: 21825246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhombencephalitis associated with isolated Zic4-antibodies in Paraneoplastic cerebellar degeneration: a case report.
    Loehrer PA; Timmermann L; Pehl A; Bien CI; Pfestroff A; Pedrosa DJ
    BMC Neurol; 2020 May; 20(1):208. PubMed ID: 32450842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebellar Ataxia With Anti-DNER Antibodies: Outcomes and Immunologic Features.
    Peter E; Do LD; Hannoun S; Muñiz-Castrillo S; Vogrig A; Wucher V; Pinto AL; Chounlamountri N; Zakaria W; Rogemond V; Picard G; Hedou JJ; Ambati A; Alentorn A; Traverse-Glehen A; Manto M; Psimaras D; Mignot E; Cotton F; Desestret V; Honnorat J; Joubert B
    Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35940913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM9 and TRIM67 Are New Targets in Paraneoplastic Cerebellar Degeneration.
    Do LD; Gupton SL; Tanji K; Bastien J; Brugière S; Couté Y; Quadrio I; Rogemond V; Fabien N; Desestret V; Honnorat J
    Cerebellum; 2019 Apr; 18(2):245-254. PubMed ID: 30350014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.